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Dialysis-related amyloidosis of the tongue in long-term hemodialysis
patients. Dialysis-related amyloidosis (DRA) predominantly occurs in the
ostcoarticular structures. However, according to studies in the increasing
number of long-term hemodialysis patients, DRA has also been systemi-
cally found to appear in the other tissues and organs as well. In this study,
we investigated lingual amyloidosis in relation to systemic DRA. A total of
472 patients were studied who were on regular hemodialysis for more than
10 years, including 103 patients for more than 20 years. Eight of these
patients (7 males and 1 female, mean age 59 8 years, range 46 to 68
years) developed lingual amyloidosis, seemingly as a result of p2-micro-
globulin (,m) deposits. All patients demonstrating lingual amyloidosis
had been treated with regular hemodialysis for more than 20 years (mean
HD duration 23.6 t 1.4 years), and its morbidity was 7.8% in the 103
patients and 20% (6 patients) in the 30 patients treated for more than 23
years with hemodialysis. Hemodialysis (HD) duration with bioincompat-
ible unsubstituted cellulose membranes in the 8 patients was longer than
that in the control group without lingual amyloidosis (P < 0.05). Lingual
amyloid nodules were whitish-yellow in color and varied in size, at least
over 1 mm in diameter. Their consistency was firmer than the intact
tongue. The location of the amyloid nodules could be classified into two
types: (I) diffuse type (diffusely distributed over the tongue), and (2)
lateral type (localized only in the lateral side of the tongue). Five of the
eight patients with lingual amyloidosis complained of functional distur-
bances in the tongue, such as abnormal taste, or difficulty in mobility and
articulation. No macroglossia was observed in any of these cases. It was
thus concluded that DRA of the tongue is a very rare complication,
occurring in the late stage of long-term hemodialysis patients, that disturbs
their quality of life.
Dialysis-related amyloidosis (DRA) is a major complication in
long-term hemodialysis patients that has been recognized as being
caused by amyloid deposition and derived from /32-microglobulin
(2m) [1]. It is also well known that DRA predominantly involves
the osteoartieular system, and is less frequently related to the
other extraarticular systems [2—81. As the number of long-term
hemodialysis patients continues to increase, DRA tends to sys-
temically appear in the extra-articular system following the onset
of osteoarticular DRA. In addition, systemic DRA-related lingual
amyloidosis has only been rarely reported [7—111. In this study, we
investigated eight patients with the lingual amyloidosis among 472
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patients maintained on regular hemodialysis treatment (RDT) for
more than 10 years. We describe the clinical and pathological
characteristics in these patients and their relation to systemic
DRA.
METHODS
Patients
A total of 472 patients, 262 males and 210 females maintained
on regular hemodialysis treatment for more than 10 years were
selected from the patients at Saiseikai Yahata Hospital and 25
other affiliated hospitals. Among them, 103 patients (70 males and
33 females; mean age 54 9 years; range 37 to 81 years) had been
treated for more than 20 years (mean HD duration 22.2 1.6
years, range 20.0 to 26.4 years). All these patients were examined
for the presence of lingual nodules. The patients underwent
regular hemodialysis for between four and five hours, three times
a week with various types of dialysis membranes without reuse.
The type of dialysate buffer was bicarbonate.
Dialysis membranes
The types of dialysis membranes used for the patients were
classified into three categories according to the established clas-
sification [12]: (1) unsubstituted cellulose membranes (Cell), (2)
modified cellulose membranes (Mod), (3) synthetic membranes
(Syn) (Table 1). Ultrafiltration coefficients (defined as the water
flux ml/mm Hg/hr) were also classified into three groups: (1) low
flux, less than 10 ml/mm Hg/hr; (2) moderate flux, greater than 10
ml/mm Hg/hr and less than 20 mI/mm Hg/hr; (3) high flux, greater
than 20 mI/mm Hg/hr.
Patients with lingual nodules
Lingual nodules were maeroscopically detected in 10 patients
and biopsied under local anesthesia. The 10 patients had been
treated by regular hemodialysis for more than 20 years. Lingual
nodules with whitish-yellow color were observed in 8 of 10
patients.
Lingual dysfunction, especially about taste, mobility, and artic-
ulation, were retrospectively studied in these 10 patients whether
or not there were any differences in the patients' complaints
before or after the appearance of lingual nodules. Lingual artie-
ulatory imprecision was finally judged by an otorhinolaryngologist
after any laryngeal disease that potentially causes articulatory
disorder was ruled out.
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Table 1. Classification of dialysis membranes
Unsubstituted cellulose Modified cellulose Synthetic
Water flux Low to high Low to high Low to high
Complement activation High Moderate to low Low
(Biocompatibility) (—) (+) (+)
Unsubstituted cellulose Cellulose acetate Polymethylmethacrylate (PMMA)
Saponified cellulose Cellulose diacetate Polyacrylonitrile (PAN)
Cuprophane Cellulose triacetate Polysulfone (PS)
Cuprammonium rayon Hemophan Polyamide (PAM)
Ethylenevinylalcohol copolymer (EVAL)
Polyester polymer alloy (PEPA)
Water flux is defined as: low, less than 10 mI/mm Hg/hr; high, greater than 20 mI/mm Hg/hr.
Table 2. Clinical features and courses of DRA in the 8 patients with lingual aniyloidosis
Tongue
CTS Bone cyst GIA Location First Final dx.
Location DSA Location (biopsy) appearance by biopsyAge Cause of First op. Frequency of op.
Patient Years Sex renal failure 1-ID years LID years Location HD years LID years
1 53 M CGN 15.7 4 L, R, L, R 14.6 Wrist 18.2 C4/5 24.3 26.4
2 46 F CGN 13 2 R, L 14 Wrist — — 19.7 23.9
3 67 M CON 18 3 R, L, R 12.3 Hip op. — — 22 23.8
4 59 M CGN 16.3 3 L, R, R 16.3 Wrist — 23.9 Rectum 22.3 23.5
5 65 M CON 15.7 2 R, L 15.7 Wrist, Hip — 23.5 Rectum 23.5 23.5
6 58 M CON 10.8 3 R, L, L 16 Wrist 20 C3/4—5/6 — 20 23.3
21.7 op.
7 52 M CGN 16 2 L, R 16 Wrist — — 18 22.9
8 68 M CGN 11.5 2 L, R 16.2 Wrist — — 19.3 21.3
Abbreviations are: CTS, carpal tunnel syndrome; DSA, destructive spondylarthropathy; GIA, gastrointestinal amyloidosis; op., operation; M, male;
F, female; CON, chronic glomerulonephritis; R, right; L, left; dx, diagnosis.
A control group comprised 24 patients (21 males and 3 females;
mean age 57 7 years, range 44 to 70 years) matched for age, sex,
HD duration (mean HD duration 23.2 1.4 years, range 20.8 to
25.7 years) with no lingual nodules.
Pathological investigations
The resected specimens of the tongue were collected from the
ten patients including two for the control. Formalin-fixed and
paraffin-embedded tissue sections were prepared for hematoxylin
and eosin (H&E), and for Congo red stainings. An immunohis-
tochemical study was performed on formalin-fixed and paraffin-
embedded tissue specimens using the labeled streptavidin biotin
method (DAKO LSAB''° Kit) [131. Rabbit anti-human /32-micro-
globulin, anti-human P component, anti-human apolipoprotein E
(Apo E), anti-human kappa light chains, anti-human lambda light
chains, anti-human prealbumin, monoclonal mouse anti-human
amyloid A component, and anti-human macrophage (CD68)
antibodies were purchased from Dakkopatts, Inc., and were used
as the primary antibodies. The primary antibodies were applied in
1:100 and 1:400 dilutions, respectively. Negative controls were
obtained by omitting the primary antibodies and replacing them
with nonimmune serum. The peroxidase was visualized with
0.001% (wt/vol) H202 and 0.005% diaminobenzidine in phos-
phate-buffered saline, pH 7.4, and then the sections were coun-
terstained with hematoxylin. For electron microscopy, the tissues
were fixed in 2% glutaraldehyde, postfixed in 1% osmium tetrox-
ide, and embedded in epoxy resin. Some of the tissues were
processed from paraffin blocks.
Blood chemistry
Predialysis serum concentration of 2-microglobulin was mea-
sured by an enzyme immunoassay (IMX 2-microdainapack;
DAINABOT, Tokyo, Japan), and that of Apo E by a turbidimetry
immunoassay in the 8 patients with amyloid lingual nodules and in
the control group.
Statistical analysis
Comparison between the 8 patients with amyloid lingual nod-
ules and a control group was done using Mann-Whitney U-test. A
P value of < 0.05 was considered statistically significant.
RESULTS
Patient profiles
Lingual nodules were observed in 10 patients, all of whom on
RDT for more than 20 years. Biopsy disclosed j32m amyloid
deposits in 8 of the 10 patients. The color of the amyloid lingual
nodules was characteristically whitish-yellow in the 8 patients.
The 8 patients with amyloid lingual nodules (7 males and 1
female; mean age 59 8 years, range 46 to 68 years) had
undergone chronic HD for an average of 23.6 1.4 years (range
21.3 to 26.4 years) at the time of diagnosis (Table 2). the
prevalence was nil for patients dialyzed for less than 20 years,
reached 8% (8 of 103) in patients dialyzed for more than 20 years
and 20% (6 of 30) in patients treated for more than 23 years.
Individual characteristics are listed in Table 2. A retrospective
assessment of the 8 patients demonstrates osteoarticular evidence
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Table 3. Duration of dialysis membranes used in the 8 patients with lingual amyloidosis
Patients with lingual
amyloidosis Control group(N= 8) (N= 24) Pvalue
Age years
Gender male/female
HD duration years
Cell duration years
Low flux cell
duration years
Duration of low flux
membranes (Cell,
Mod, Syn) years
132m mg/liter
ApoE mg/dl
Abbreviations are: Cell, unsubstituted cellulose membrane; Mod, mod-
ified cellulose membrane; Syn, synthetic membrane; 13,m, /37-microglobu-
lin; ApoE, apolipoprotein E; NS, not significant.
of DRA in each patient as demonstrated by CTS operation (10.8
to 18 years after the onset of dialysis), typical bone cysts according
to established criteria (12.3 to 16.3 years after onset of dialysis)
[141. In addition, two patients (Patients 1 and 6) suffered from
destructive spondylarthropathy (DSA) (18.2 to 21.7 yeas after
onset of dialysis) while the other 2 (Patients 4 and 5) demon-
strated gastrointestinal amyloidosis confirmed by rectal biopsy
(23.5 to 23.9 years after onset of dialysis). These 8 patients had
already noticed their lingual nodules before final diagnosis was
made by lingual biopsy. The mean duration of hemodialysis was
21.1 2.2 years when they became aware of lingual nodules.
Lingual amyloidosis appeared after CTS and bone cysts.
Dialysis membranes
The types of dialysis membranes used for the entire duration of
hemodialysis in the 8 patients with lingual amyloidosis are shown
in Table 3 according to the classification of dialysis membranes
(Table 1). The total duration of unsubstituted cellulose (Cell) was
longer than those of modified cellulose (Mod) and synthetic
(Syn). The mean duration of Cell was 20.8 2.4 years (Table 4),
most of which utilizing low flux Cell (mean duration: 18.6 2.3
years). Hemodialysis duration of Cell was significantly longer (P <
0.05) in the 8 patients with lingual amyloidosis than in the control
group. In addition, hemodialysis duration of low flux Cell was also
significantly longer in the 8 patients than in the control group (P <
0.01), while no difference was observed in total number of years of
low flux dialysis membranes (Cell, Mod, Syn).
Clinical characteristics
NS The amyloid nodules of the tongue were whitish-yellow in color
NS and appeared in various sizes greater than 1 mm in diameter
(Figs. 1 and 2). The nodules was firmer in consistency than other
<001 intact area of the tongue. The locations were classified into two
types: the lateral type (Fig. 1) and the diffuse type (Fig. 2). There
was no difference in the hemodialysis duration of these two types.
No macroglossia was seen even in the diffuse type. DRA of the
tongue induced the following lingual dysfunctions: (1) loss of
feeling or abnormal taste; (2) disturbed mobility; (3) lingual
articulatory imprecision (Table 5). Four (Patients 4, 5, 6, 7) of the
8 patients complained of a taste disturbance, and were all diffuse
type. Two (Patients 2 and 7) of them presented a disturbed lingual
mobility. Only patient 7, the most severe case of all, developed
inaccurate lingual articulation (Table 5). The other two patients
with 2m non-related lingual nodules didn't complain of lingual
dysfunction. Though we measured the predialysis serum levels of
f37m and Apo E, no difference was found between the 8 patients
and the control group (Table 4).
Histological characteristics
A histological characteristic of the lingual amyloidosis was
massive arnyloid depositions distributed from the subepithelium
to the deeper muscle layer in all tongue specimens, which were
confirmed to react with antibodies to human 13,m. In the light
microscopic study, the specimens showed amorphous, eosino-
philic deposits diffusely from the suhepithelium to the deeper
muscle layer (Fig. 3), strongly stained for Congo red, and showed
an apple-green birefringence under crossed polarized light. These
all specimens were thus diagnosed as amyloid deposits. An
immunohistoehemical study, using the labeled streptavidin biotin
method (DAKO LSAB Kit), demonstrated amyloid deposits that
were confirmed to react with antibodies to human amyloid P
component, Apo E, and 2m as well. However, no immunoreac-
tivity was observed to the amyloid A protein, kappa light chain,
lambda light chain, or prealbumin. Multinucleated giant cells,
scattered in the peripheral area of the amyloid deposits, were also
stained with anti-CD68 antibody in all cases, thus suggesting that
they were derived from macrophage-related cells. An electron
Membranes years
Cell Total of Cell
Water flux Low Moderate High Low to high
Mod
Moderate Low High
Total of Mod & Syn
Low to high
— + + + +Biocompatibility
Patient 1 17.4 1.8 5.7 24.9 1.5 1.5
2 14.5 4.3 1.6 20.4 2.1 1.4 3.5
3 18.5 2.3 1.6 22.4 1.4 1.4
4 18.1 0.1 18.2 2.8 2.5 5.3
5 19.4 19.4 4.1 4.1
6 18.8 18.8 0.8 3.1 0.7 4.6
7 22.9 22.9
8 19.4 19.4
cellulose; Syn, synthetic.
1.8 1.8
Abbreviations are: Cell, unsubstituted cellulose; Mod, modified
Table 4. Statistical analysis between the 8 patients with lingual
amyloidosis and the control group
59 8
7/1
23.6 1.4
20.8 2.4
18.6 2.3
19.6 2.2
28.7 8.3
4.8 1.0
58 7
21/3
23.2 1.4
17.0 4.5
14.7 3.4
17.7±3.1 NS
27.6 8.4 NS
4.9 2.2 NS
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Fig. 1. The diffuse type of the lingual
amyloidosis (Patient 7 in Table 2). Amyloid
nodules of various size are diffusely observed
on the tongue of our most severe case.
Fig. 2. The lateral type of the lingual
amyloidosis (Patient 2 in Table 2). Aniyloid
nodules are observed on the lateral side of the
tongue.
microscopic study revealed the typical fibrillar structure of amy-
bid. The fibrils were arranged in parallel and nonbranching,
curvilinear bundles (Fig. 4).
DISCUSSION
In this study, we investigated the clinical and pathological
characteristics of lingual amyloidosis in relation to systemic DRA.
Among our 472 patients undergoing RDT for more than 10 years,
including 103 patients for more than 20 years, eight patients
whose HD duration was more than 20 years developed lingual
amyloidosis (Table 2). The HD duration was at least 18 years
before the nodules were found by patients themselves, although it
was not obvious whether or not they were lingual amyboidosis. In
the previous case reports (Table 6) [7-11], the shortest duration of
Table 5. Clinical characteristics of lingual amyboidosis
Location of
amyboid nodules
Patient Lateral Dorsum Macroglossia
Functianal disturbance of the
tongue
Taste Mobility Articulation
I L,R -
2 L,R
3 L,R -
4 L,R +
5 L,R +
6 L,R +
7 L,R +
8 L,R -
-
—
—
—
—
-
—
-
-
—
—
+
+
+
+
-
- -
+ —
- -
— —
—
- —
+ +
- -
Abbreviations are: Lateral, lateral side of the tongue; Dorsum, dorsum
of the tongue; L, left; R, right.
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Fig. 3. The light microscopic findings of the
tongue (Patient 7 in Table 2). Amorphous and
eosinophilic amyloid depositions are diffusely
seen between the subepithelium and the deeper
muscle layer. Mononuclear cells scatteredly
infiltrated between them (hematoxylin & eosin
stain, X40).
Fig. 4. The electron microscopic findings of the
tongue (Patient 6 in Table 2). The amyloid
fibrils were arranged in parallel and curvilinear
bundles (x25,000).
HD was 12 years, less than that of our study groups. However, we
cannot directly compare our 8 patients with them because of the
lack of information about their HD conditions such as type of
dialysis membrane, dialysate, reuse of dialyzer, or water purifica-
tion system.
All of our 8 patients experienced DRA of the osteoarticular
system (Table 2). In the literature, the prevalence of osteoarticu-
lar lesions attributable to 2m amyloid, like the prevalence of
CTS, is reported to increase with the duration of RDT [15].
Beyond 15 years, virtually 100% of hemodialysis patients develop
osteoarticular lesions [16j. In our 8 patients, DRA of the gastro-
intestinal tract and the tongue appeared later than osteoarticular
DRA. DRA can thus be classified into two stages, namely the
initial and the late stages. The former is well known as osteoar-
ticular DRA while the latter is extraarticular DRA. We consider
that DRA of the tongue should be included in the late stage group
since it tends to predominantly occur in patients with longer
regular hemodialysis, such as those undergoing hemodialysis
treatment for more than 20 years.
Regarding the dialysis membranes in our 8 patients, bioincom-
patible, unsubstituted cellulose membranes had been used for a
considerably long period (mean duration 20.8 2.4 years)
compared to the control group (Table 4), which may have
accelerated the production of j32m [15, 17]. Although many
factors are involved, the chief prerequisite for the development of
DRA may be grossly elevated serum concentrations of J32m, which
remains high for a prolonged period [151. We thus suggest that
prolonged HD duration of cellulose membranes (Cell) for more
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Table 6. Previous case reports of lingual amyloidosis of DRA
Case
Authors
[referencel
Pati
Age
ents
Sex
Cause of
renal failure
Duration
of HD
.
Dialysis
membrane Symptoms Nodules Macroglossia
1 Fuchs et al [10] 56 M CGN 18Y Cuprophane Odynophagia Rt side —
2 Ogawa et al [71 54 M CGN 12Y ND — — — Autopsy
3 Guccion et al [8] 50 M CGN 12Y ND — Dorsal, lateral,
pale-yellowish
— Nodule size:
0.2—0.6 cm
4 Sethi et al [9] 48 M Crescentic
GN
18Y Cuprophane Unpleasant taste
difficulty swallowing
+ +
5 Yuonai et al [11] 66 M ND ND ND — Dorsum —
Abbreviations are: M, male; CGN, chronic glomeruloneprhitis; Y, years; ND, no data.
than 20 years is one of the contributing factors that may induce
DRA of the tongue. In patients in which DRA is already
established, biocompatible "high-flux" synthetic membranes
should be used for hemodialysis, since they can significantly
reduce the prevalence of DRA [14, 18, 19] and thereby improve
such symptoms [20, 21].
In regard to the clinical signs and symptoms of lingual amyloid-
osis in our cases (Table 5), the location of the amyloid nodules was
classified into two types: the lateral type (Fig. I) and the diffuse
type (Fig. 2). No lingual amyloidosis was found in the amyloid
nodules deposited only in the dorsum of the tongue, while Yuonai
and Sciubba reported that amyloid nodules deposited on the
dorsum of the tongue [111. It is doubtful whether they precisely
checked the lateral side of the tongue as well, because patients 6
and 7 of the diffuse type in our cases initially noticed the nodules
only on the lateral side. We thus speculate that amyloid deposition
predominantly starts on the lateral side of the tongue due to
frequent contact with the teeth and related stimulation.
There was no macroglossia, although macroglossia is frequently
seen as a sign of arnyloidosis in primary and myeloma-related
amyloidosis (AL amyloidosis). Macroglossia is estimated to occur
in 20% to 27% of such amyloidosis patients [22—251. Lingual
amyloid lesions, macroglossia in particular is less frequent in
secondary amyloidosis (AA amyloidosis, etc.) than in the primary
or myeloma associated types. Although only one case of macro-
glossia has been previously reported by Sethi et al [9] as a case of
systemic DRA (Table 6), it has yet to be clarified as to whether or
not the tongue was enlarged. For clinical diagnosis of macroglos-
sia, the following conditions are required: (1) increased firmness
of the enlarged tongue, (2) enlargement of the submandibular
structures, and (3) dental indentations on the tongue. When these
clinical appearances are present, then the diagnosis of macroglos-
sia can be made. Lingual dysfunctions in mobility and articulation
are also typical in macroglossia, but less frequently observed in
our patients due to a lack of macroglossia. Only one patient (Fig.
2), the most severe case, developed them even without any clinical
signs of macroglossia. Therefore, macroglossia is not a typical sign
of lingual amyloidosis in long-term hemodialysis patients.
Many patients in our study also complained of lingual dysfunc-
tion (Table 5). Impaired taste occurred only in diffuse type
(Patients 4, 5, 6, and 7). Therefore, such symptoms were consid-
ered to be due to amyloid nodules in the dorsal lesion. Symptom-
atic lingual amyloid deposition has been reported only in two
cases as far as we know [10, 11] (Table 6). In our 8 patients, we did
not find any symptoms of odynophagia or difficulty in swallowing.
Immunohistochemically, amyloid nodules of the resected spec-
imen reacted with anti-human 2m, amyloid P component, and
Apo E antibodies. The amyloid P component is known to be
commonly associated with all types of systemic amyloidosis [26—
29], although its role in the process of amyloidogenesis still
remains to be clarified. Recently, Apo E was demonstrated to
have an affinity to f3-amyloid protein, which forms amyloid fibrils
in Alzheimer's disease [30]. In addition, recent studies showed
that Apo E peptides are commonly associated with amyloid
deposits in cases of systemic amyloidosis [31, 32]. The potential
role of the amyloid P component and Apo E in amyloidogenesis
needs to be investigated further. In our study, the predialysis
serum levels of 132n1 and Apo E were compared between our 8
patients and the control group (Table 4). No difference was
discovered between the two groups, which seemed compatible
with those in previous studies [33, 34].
In conclusion, dialysis-related amyloidosis of the tongue is a
very rare complication in the late stage of long-term hemodialysis,
however, this problem may cause serious lingual dysfunction,
affecting the patients' quality of life.
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